PracticeFARFree practice exam

FAR · Select balance sheet accounts · 6 practice questions

Finite-Lived Intangible Impairment: Cash Flows vs. Fair Value

For a finite-lived intangible held and used, test its asset group's recoverability with undiscounted cash flows before measuring any loss at fair value. Follow Noll's product line through a decision tree that changes only the cash-flow estimate.

The ruleWhen impairment indicators exist, compare the asset group's carrying amount with undiscounted cash flows from use and eventual disposition. If carrying amount exceeds those cash flows, measure the loss as carrying amount minus fair value.

Try one first

At 12/31/X5, Noll Co. evaluates certain intangible assets for impairment after an adverse industry development. Assume the following facts under U.S. GAAP: 1. Patent: The patent is finite-lived and amortized. It is used only in Product Line A together with specialized equipment. Product Line A is the lowest level of identifiable cash flows, and the patent does not generate cash inflows independently of the equipment. Carrying amounts are: patent $320,000 and equipment $780,000. Expected undiscounted future net cash flows of Product Line A are $1,140,000. The patent's standalone fair value is $210,000. 2. Trade name: The trade name is indefinite-lived and is not amortized. It is not grouped with other assets for impairment testing. Its carrying amount is $260,000 and its fair value is $225,000. Noll elects not to perform any optional qualitative assessment. No assets are held for sale. Which conclusion is best supported?
Hint

Separate the finite-lived and indefinite-lived intangibles before doing any math, and decide whether the patent is tested by itself or with other assets.

Decide it in order

  1. T1Noll's product line is the lowest level with largely independent cash flows. Its finite-lived patent depends on equipment; both are held and used. After amortization, group carrying amount is $1,000,000 and fair value is $800,000. Expected undiscounted cash flows are $900,000. An adverse market change occurs. Is there an impairment indicator?

    NoWithout an impairment indicator, no recoverability test is required for these finite-lived assets.
  2. T2Does the patent generate cash flows largely independent of the equipment?

    YesTest the patent separately using its own carrying amount and undiscounted cash flows. Use its fair value only if recoverability fails.
  3. T3Choose the cash-flow case, then test: do undiscounted cash flows from use and eventual disposition equal or exceed $1,000,000? Base case: $900,000. Same facts, except undiscounted cash flows are $1,100,000 and their discounted value is $800,000. Carrying amount remains $1,000,000 and fair value remains $800,000.

    YesComparison case: the group is recoverable, so impairment is $0 despite its $800,000 fair value. Using discounted cash flows would incorrectly trigger a $200,000 write-down.
  4. T4The base case fails recoverability because $900,000 is below $1,000,000. Is the group's fair value below its $1,000,000 carrying amount?

    YesRecognize a $200,000 impairment loss: $1,000,000 minus $800,000 fair value. Report the group at $800,000, not $900,000.
    NoNo impairment loss is measured when fair value equals or exceeds carrying amount.

Key points

  • Remember: Undiscounted cash flows decide whether to write down; fair value decides how far.
  • Use carrying amount after amortization, not original cost.
  • A low fair value alone cannot trigger a write-down when the group passes recoverability.

How the exam traps you

  • Testing Noll's patent separately from the equipment. The patent lacks independent cash flows, so test it with the product line's asset group.
  • Using the comparison case's $800,000 discounted cash flows to fail recoverability. Use $1,100,000 undiscounted cash flows; impairment is $0, not $200,000.
  • Measuring the base-case loss as $1,000,000 minus $900,000, or $100,000. After recoverability fails, subtract $800,000 fair value instead. The loss is $200,000.

5 more, each from a different angle

0 of 5 answered · 0 correct

Question 2

At Dec. 31, Year 2, Noll Co. evaluated three intangible assets for impairment. Assume each asset’s cash flows are largely independent of other assets, so each asset is tested separately. No asset is classified as held for sale, and no prior impairments have been recorded.
AssetLifeCarrying AmountUndiscounted Future Cash FlowsFair Value
PatentFinite$480,000$450,000$410,000
Customer listFinite$230,000$250,000$200,000
TrademarkIndefinite$300,000, $260,000
What total impairment loss should Noll recognize on these intangible assets at Dec. 31, Year 2?
Hint

Separate the assets by life: finite-lived intangibles do not use the same impairment screen as indefinite-lived intangibles.

Question 3

Maxwell Co. purchased a trademark on January 1, Year 1 for $6,000,000 and recorded it as a finite-lived intangible with a 10-year straight-line useful life (no residual value). Maxwell recorded three full years of amortization (Years 1-3). On January 1, Year 4 management concludes the trademark's life is indefinite and reclassifies it as an indefinite-lived intangible. What is the effect on Maxwell's balance sheet at January 1, Year 4 and in subsequent years?
Hint

Decide whether changing a previously estimated useful life is an accounting estimate or a change in principle, then apply the prospective accounting rule and the impairment-testing requirement for indefinite-lived intangibles.

Question 4

On January 1, Year 1, Harlan Co. acquired a registered trade name for $900,000. The registration is renewable every 10 years at nominal cost, Harlan intends and is able to renew it indefinitely, and no legal, regulatory, contractual, competitive, or economic factors limit the period over which the trade name is expected to contribute to cash flows. During Year 1, Harlan paid $60,000 of legal fees to successfully defend the trade name against infringement and $40,000 for an advertising campaign promoting the brand. Harlan performs the required annual impairment test on December 31, Year 1, and the trade name's fair value at that date is $880,000. Under U.S. GAAP, which amount and treatment is most appropriate at December 31, Year 1?
Hint

Separate three decisions: useful life classification, which Year 1 costs become part of the intangible's carrying amount, and how impairment is measured once fair value is given.

Question 5

On January 1, Year 1, Meridian Co. purchased a trademark for $600,000 and classified it as indefinite-lived because management expects to renew the registration at minimal cost indefinitely. The trademark has not been amortized. On December 31, Year 2, Meridian estimates the trademark's fair value to be $380,000 because of a substantial and sustained decline in market demand. Under U.S. GAAP, what is the most appropriate effect or consequence of this information on Meridian's Year 2 balance sheet accounts?
Hint

First determine whether the trademark is finite- or indefinite-lived; then recall which impairment test and presentation (net income vs OCI) U.S. GAAP requires for indefinite-lived intangibles.

Question 6

On 1/1/20X1, Lark Co. acquired a tradename for $900,000 and properly classified it as an indefinite-lived intangible asset. No impairment was recognized through 12/31/20X3. On 7/1/20X4, Lark approved and committed to a rebranding plan that is expected to eliminate any economic benefit from the tradename after 6/30/20X9. On 7/1/20X4, before recording any 20X4 entry related to the tradename, its carrying amount was $900,000 and its fair value was $840,000. Assume Lark will continue to hold and use the tradename, no disposal-group issues exist, and the revised useful life estimate is supportable under U.S. GAAP. What is the consequence of the 7/1/20X4 change for Lark's accounting for the tradename?
Hint

Focus on the required order of analysis when an intangible asset changes from indefinite-lived to finite-lived.

Drill all 107 Intangible assets questionsMixed across every rule in the topic, so you have to spot which one applies. That is how the exam does it.

Common questions

Do finite-lived intangibles use discounted cash flows for recoverability?

No. Noll's comparison case passes because $1,100,000 of undiscounted cash flows exceeds $1,000,000. Using the $800,000 discounted value would wrongly trigger a $200,000 loss.

Is a finite-lived patent tested alone or with its asset group?

Use the lowest level with largely independent cash flows. Noll's patent depends on the equipment, so test the product line's asset group rather than the patent alone.

How do you calculate a finite-lived intangible impairment loss?

First, the asset group must fail the undiscounted recoverability screen. Noll's base-case loss is then $1,000,000 carrying amount minus $800,000 fair value, or $200,000.

Watch it solved

A full CPA FAR task-based simulation on Intangible assets, worked step by step.

Patent Cost, Amortization & Impairment | CPA FAR Simulation (TBS) on YouTube

Practice FAR like the real exam

The free ChatCPA simulator: real exam layout, timed testlets, starting with a question on this topic. No account needed to start.

Open the free simulator →

More on Intangible assets

All Intangible assets practice →

Questions from the ChatCPA bank of 17,658 CPA exam questions, each with a written reason for every wrong answer. ChatCPA is built by Nicholas Miller, CPA (Oregon #14907). How these pages are made. Spot an error? Tell us.